EFPIA Newsletter 11 January 2018

Vacancies

Blogs     09 January 2018 09012018 A healthier 2018 Opportunities and challenges for the year ahead Read more →

Events     22 JAN 2018   04102017 SafeSciMET Courses on regulatory requirements and guidelines Lisbon, Portugal A course to provide participants with a comprehensive overview of the required in vitro and in vivo nonclinical studies,... Learn more →       23 JAN 2018   15122017 Patients as Partners EU London, UK How to involve patients throughout the entire medicines development lifecycle, to drive greater efficiencies in clinical... Learn more →

	26 FEB 2018			06122017 4th European Conference on Clinical Research Vienna, Austria A EUCROF conference Learn more →

	10 MAY 2018			13122017 European Conference on Rare Diseases and Orphan Products Messe Wien Congress Center, Vienna, Austria The largest multi-stakeholder gathering in Europe for the rare disease community Learn more →

What we are reading Five reasons why #WeWontRest 19 December 2017  (LillyPad EU) Read more → Bill Gates Thinks These 6 Innovations Could Change the World 04 January 2018  (Time) Read more → Commission reassures ‘worried’ member states on Health Technology Assessment 10 January 2018  (EurActiv) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe